PharmTech Drug Digest 11.20
|Articles|September 5, 2014

Patient-centric Considerations for Intradermal Delivery via Hollow Microneedles

In this podcast, you will get an overview of hollow microneedle drug delivery and the importance that human factor research plays in the design and use of these devices.

In this podcast, you will get an overview of hollow microneedle drug delivery and the importance that human factor research plays in the design and use of these devices.

To find out more about hMTS and 3M Drug Delivery Systems, please visit ref="go.3M.com/Microneedle" target="_blank">go.3M.com/Microneedle


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.